Cempra has two antibiotic candidates, solithromycin (CEM-101) and TAKSTA™ (CEM-102, sodium fusidate), in clinical trials. Both target the growing problem of antimicrobial resistance.
Solithromycin is a next-generation macrolide, the first fluorok...查看全文
$Cempra(CEMP)$ 美东时间 2014-03-03 13:30 Cempra Inc at Cowen Health Care Conference 网页链接
$Cempra(CEMP)$ 美东时间 2014-02-12 14:40 Cempra Inc at Leerink Swann Global Healthcare Conference 网页链接
$Cempra(CEMP)$ 美东时间 2014-02-11 13:00 Cempra Inc at Biotechnology Industry Organization CEO & Investor Conference 网页链接
$Cempra(CEMP)$ 美东时间 2013-12-11 15:55 Cempra Inc at Oppenheimer Healthcare Conference 网页链接
$Cempra(CEMP)$ 美东时间 2013-12-04 14:30 Cempra Inc at Piper Jaffray Healthcare Conference 网页链接
$Cempra(CEMP)$ 美东时间 2013-11-20 08:00 Cempra Inc at Jefferies London Healthcare Conference 网页链接
$Cempra(CEMP)$ 美东时间 2013-11-19 14:25 Cempra Inc at Elsevier Business Intelligence Therapeutic Area Partnerships Conference 网页链接
$Cempra(CEMP)$ 美东时间 2013-10-29 16:30 After Market Close:CEMPRA INC Earning Release .Wall St EPS Est ($):-0.31.网页链接
$Cempra(CEMP)$ 美东时间 2013-09-27 13:30 Cempra Inc at BioCentury NewsMakers in the Biotech Industry Conference 网页链接
$Cempra(CEMP)$ 美东时间 2013-09-27 14:00 Cempra Inc at BioCentury NewsMakers in the Biotech Industry Conference 网页链接